PT1102586E - Utilizacao de extractos de ginkgo biloba para a preparacao de um medicamento para o tratamento da esclerose lateral amiotrofica - Google Patents

Utilizacao de extractos de ginkgo biloba para a preparacao de um medicamento para o tratamento da esclerose lateral amiotrofica

Info

Publication number
PT1102586E
PT1102586E PT99936702T PT99936702T PT1102586E PT 1102586 E PT1102586 E PT 1102586E PT 99936702 T PT99936702 T PT 99936702T PT 99936702 T PT99936702 T PT 99936702T PT 1102586 E PT1102586 E PT 1102586E
Authority
PT
Portugal
Prior art keywords
ginkgo biloba
lateral sclerosis
medication
preparation
treatment
Prior art date
Application number
PT99936702T
Other languages
English (en)
Inventor
Christen Yves
Original Assignee
Conseils Rech S Et D Applic Sc
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Conseils Rech S Et D Applic Sc, Scras filed Critical Conseils Rech S Et D Applic Sc
Publication of PT1102586E publication Critical patent/PT1102586E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
PT99936702T 1998-08-07 1999-08-06 Utilizacao de extractos de ginkgo biloba para a preparacao de um medicamento para o tratamento da esclerose lateral amiotrofica PT1102586E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9810187A FR2782008B1 (fr) 1998-08-07 1998-08-07 Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a traiter la sclerose laterale amyotrophique

Publications (1)

Publication Number Publication Date
PT1102586E true PT1102586E (pt) 2005-02-28

Family

ID=9529516

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99936702T PT1102586E (pt) 1998-08-07 1999-08-06 Utilizacao de extractos de ginkgo biloba para a preparacao de um medicamento para o tratamento da esclerose lateral amiotrofica

Country Status (12)

Country Link
US (1) US6524629B1 (pt)
EP (1) EP1102586B1 (pt)
JP (1) JP4510289B2 (pt)
AT (1) ATE281162T1 (pt)
AU (1) AU5170499A (pt)
CA (1) CA2340021C (pt)
DE (1) DE69921662T2 (pt)
ES (1) ES2230873T3 (pt)
FR (1) FR2782008B1 (pt)
NO (1) NO327733B1 (pt)
PT (1) PT1102586E (pt)
WO (1) WO2000007592A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2785808B1 (fr) * 1998-11-13 2002-12-06 Aventis Laboratoire Association riluzole et alpha-tocopherol
FR2827518B1 (fr) * 2001-07-17 2005-07-08 Sod Conseils Rech Applic Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a traiter la sarcopenie
JP4528490B2 (ja) * 2002-06-25 2010-08-18 和光化学株式会社 ギンコライド−ａを含有する抗不安剤
US8024893B2 (en) 2003-02-19 2011-09-27 Pilkington North America, Inc. Powered slider drive interface and drive assembly
EP1626693A2 (en) * 2003-05-02 2006-02-22 Georgetown University Ginkgo biloba extract as a treatment for therapeutic- induced neurotoxicity
WO2006004386A1 (es) * 2004-07-02 2006-01-12 Rojas Castaneda Patricia Uso de un extracto del ginkgo biloba para preparar una medicina para tratar la enfermedad de parkinson
US20090197279A1 (en) * 2005-09-30 2009-08-06 Kinemed, Inc. Microtubule synthesis as a biomarker
WO2007081910A2 (en) 2006-01-05 2007-07-19 Kinemed, Inc. Compositions and methods of treatment using modulators of motonueron diseases
FR2904222A1 (fr) * 2006-07-27 2008-02-01 Sod Conseils Rech Applic Utilisation d4extraits de ginkgo biloba pour le traitement de maladies mitochondriales
CA2725138A1 (en) * 2008-05-21 2009-11-26 Kinemed, Inc. Compositions and methods of treatment using modulators of motoneuron diseases
GB0922064D0 (en) 2009-12-17 2010-02-03 Pilkington Group Ltd Soda lime silica glass composition
EP2804598B1 (en) * 2012-01-17 2019-05-15 Kyoto University Prophylactic and therapeutic drug for amyotrophic lateral sclerosis and method of screening therefor
WO2016114655A1 (en) * 2015-01-12 2016-07-21 Ry Pharma B.V. Treating neuromuscular or neurologic disease through reducing gabaergic and/or glycinergic inhibitory neurotransmitter overstimulation
WO2017065602A1 (en) * 2015-10-13 2017-04-20 Ry Pharma B.V. Treating neuromuscular or neurologic disease through reducing gabaergic and/or glycinergic inhibitory neurotransmitter overstimulation
CN108096243B (zh) * 2017-11-24 2020-05-29 江苏康缘药业股份有限公司 银杏内酯组合物的医药用途
CN110893183A (zh) * 2018-09-13 2020-03-20 成都百裕制药股份有限公司 银杏萜内酯在制备预防、缓解或治疗肌萎缩侧索硬化药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3338995A1 (de) * 1983-10-27 1985-05-09 Dr. Willmar Schwabe GmbH & Co, 7500 Karlsruhe Bilobalid enthaltende arzneimittel
DE3940094A1 (de) * 1989-12-04 1991-06-06 Montana Ltd Wirkstoffkonzentrate und neue wirkstoff-kombinationen aus blaettern von ginkgo biloba, ein verfahren zu ihrer herstellung und die wirkstoff-konzentrate bzw. die wirkstoff-kombinationen enthaltenden arzneimittel
DE4328374A1 (de) * 1993-08-24 1995-03-02 Deinlein Kalb Hans Neue Verwendung eines Extraktes aus den Blättern von Ginkgo biloba
EP0866704B1 (fr) * 1995-10-26 2001-04-11 Sanofi-Synthelabo Utilisation de la 1-(2-napht-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de la sclerose laterale amyotrophique

Also Published As

Publication number Publication date
US6524629B1 (en) 2003-02-25
JP4510289B2 (ja) 2010-07-21
DE69921662T2 (de) 2005-10-20
AU5170499A (en) 2000-02-28
ATE281162T1 (de) 2004-11-15
FR2782008A1 (fr) 2000-02-11
EP1102586A1 (fr) 2001-05-30
ES2230873T3 (es) 2005-05-01
CA2340021A1 (fr) 2000-02-17
WO2000007592A1 (fr) 2000-02-17
NO327733B1 (no) 2009-09-14
FR2782008B1 (fr) 2003-04-25
DE69921662D1 (de) 2004-12-09
EP1102586B1 (fr) 2004-11-03
NO20010627L (no) 2001-02-06
NO20010627D0 (no) 2001-02-06
JP2002522387A (ja) 2002-07-23
CA2340021C (fr) 2009-09-15

Similar Documents

Publication Publication Date Title
PT1102586E (pt) Utilizacao de extractos de ginkgo biloba para a preparacao de um medicamento para o tratamento da esclerose lateral amiotrofica
ATE205086T1 (de) Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit
ATE265857T1 (de) Pharmazeutische oder diätetische zusammensetzung zur prävention oder behandlung von hyperoxalurie
ZA200300712B (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and Behcet's syndrome.
PT1040830E (pt) Medicamento para doencas neurodegenerativas
WO1994008551A3 (en) Pharmaceutical compositions and methods for treating cold symptoms
HK1069327A1 (en) Use of ginkgo biloba extracts for preparing a medicine for treating sarcopenia
HK1068606A1 (en) Novel aminobenzoephenones
WO2001030335A3 (en) Pharmaceutical compositions useful in the prevention and treatment of beta-amyloid protein-induced disease
HK1068106A1 (en) Use of sarp-1 for the treatment and/or prevention of scleroderma
DE69918961D1 (de) Verbesserte inhalationspräparate
AU7862401A (en) Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
EP0744176A3 (en) Methods for inhibiting bone loss
BR0116373A (pt) Utilização de tienilciclo-hexilamina, produto, e, composições farmacêuticas
DE69823226D1 (de) Pharmazeutische zusammmensetzung, enthaltend ticlopidin und ginkgo biloba extrakt
PL374841A1 (en) Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass
HUP9802896A3 (en) Optically active piperidinoalkyl-4h-1,2,4-oxadiazine derivative, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
HUP9902469A3 (en) Use of ginkgo biloba extracts for the preparation of pharmaceutical compositions, and method of cosmetic treatment using a ginkgo biloba extract
BR0106527A (pt) Composto fitoterápico para tratamento da úlcera venosa
IT1304852B1 (it) Miscela di piante medicinali per la prevenzione e la cura delleemorroidi.
AU2427300A (en) Use of extracts from ginkgo biloba leaves for treating sleep disorders
WO2000067733A3 (de) Medikament zur therapie der männlichen infertilität